nabokovsnose

Keith Obaman. Well-known pundit. I don't think he has a chance though.

Do you think pharmaceutical companies would jump at the chance to research CBD for pain management if those regulatory constraints were lifted?

I have additional question: How often do you run these trials and how do you ensure they're safe? Given that opiates are pretty addictive, this seems like a pretty big concern, recreational users or not.

I found the link in the description.